Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02910115Terminated
Randomised, open-label trial (2 arms), sponsored by Baylor Scott & White Research Institute. Primary endpoint: Estimated Blood Loss at 24 hours. Started May 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02910115.